Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06386861 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Validating the Spanish "Attitudes Toward Genomics and Precision Medicine" (AGPM).

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Dec 31, 2024 to Dec 31, 2025v3
  2. Trial status: Recruiting to Active, Not Recruitingv2 Show 5 more changesShow less
    • Enrollment target: estimated 1000 to confirmed 851
    • Primary completion date changed from estimate of May 31, 2024 to Apr 15, 2024
    • Eligibility criteria revised
    • Site details revised
    • Study description expanded, about 1 word
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators aim to evaluate English and Spanish versions of the "Attitudes toward genomics and precision medicine" instrument (AGPM). This study will help validating a Spanish version of the AGPM among people identifying as Hispanic, Latino, or Latina. Having a valid instrument is important for developing tailored interventions to decrease disparities in genomic healthcare for this population.
Trial Details
NCT Number NCT06386861
Lead Sponsor Boston College
Conditions
(from sponsor)		 Adult ALL
Related terms Behavior, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Enrollment 851 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov